Nebius Stock (NBIS) Jumps on Reports of a $19B Deal with Microsoft (MSFT)

Nebius (NBIS) stock rallied on reports of a potential $19.4 billion deal with Microsoft (MSFT) to provide over 100,000 Nvidia GB300 chips for AI computing power, building on earlier unconfirmed news. This reported agreement underscores Microsoft's strategy to secure essential infrastructure for its AI initiatives, similar to partnerships with other cloud providers. NBIS shares rose 4.6% on Thursday, extending substantial year-to-date gains, despite the deal not being officially confirmed by either company.

Analysis

Nebius (NBIS) is experiencing significant positive momentum following reports of a potential $19.4 billion deal with Microsoft (MSFT), which would grant the tech giant access to over 100,000 of Nebius's Nvidia (NVDA) GB300 chips for its AI infrastructure. This news, while not officially confirmed by either party, builds upon earlier unconfirmed reports from September and provides specific financial details that underscore the scale of the potential partnership. The market has reacted favorably, with NBIS stock climbing 4.6%, adding to its substantial year-to-date rally of 339.17%. This reported agreement fits within Microsoft's established strategy of securing AI computing capacity through partnerships, similar to its existing deals with CoreWeave and others, highlighting the intense demand for specialized AI hardware. Despite the stock's strong performance, trading volume of 5.34 million shares remains below the three-month daily average of 18.1 million, suggesting potential investor caution pending official confirmation. Wall Street maintains a 'Moderate Buy' consensus with an average price target of $136.40, implying a 13.5% upside, which indicates that while analysts are optimistic, a significant portion of the positive outlook may already be reflected in the current valuation.

Key Decisions for Investors

• Investors should prioritize monitoring for official confirmation of the deal from Nebius or Microsoft, as this event will serve as the primary validation or invalidation of the current rally.
• Given the stock's significant 339% year-to-date appreciation, existing holders might consider trimming positions to realize profits and de-risk against the possibility of the deal not materializing.
• Potential investors should be cautious about initiating new positions at these elevated levels, as the investment thesis hinges on an unconfirmed report, and a failure to confirm could trigger a sharp price correction.